BioRender 图标

Pseudostratified epithelial cell 2 (damaged)

Pseudostratified epithelial cell 2 (damaged) - Editable icon of Pseudostratified epithelial cell 2 (damaged)
[{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb37086/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb37086/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb37087/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb37087/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb37088/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb37088/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb37089/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb37089/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb3708a/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb3708a/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb3708b/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb3708b/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb3708c/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb3708c/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb3708d/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb3708d/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb3708e/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb3708e/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb3708f/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb3708f/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb37090/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb37090/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb37091/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb37091/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb37092/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb37092/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb37093/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb37093/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb37094/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb37094/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb37095/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb37095/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb37096/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb37096/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb37097/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb37097/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb37098/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb37098/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb37099/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb37099/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb3709a/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb3709a/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb3709b/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb3709b/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb3709c/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb3709c/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb3709d/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb3709d/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb3709e/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb3709e/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb3709f/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb3709f/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370a0/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370a0/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370a1/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370a1/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370a2/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370a2/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370a3/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370a3/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370a4/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370a4/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370a5/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370a5/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370a6/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370a6/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370a7/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370a7/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370a8/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370a8/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370a9/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370a9/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370aa/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370aa/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370ab/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370ab/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370ac/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370ac/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370ad/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370ad/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370ae/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370ae/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370af/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370af/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370b0/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370b0/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370b1/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370b1/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370b2/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370b2/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370b3/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370b3/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370b4/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370b4/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370b5/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370b5/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370b6/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370b6/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370b7/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370b7/5d1e63f409f8320400b7f3cd.png"}]
使用此图标 – 免费
注册无需信用卡。

此图标可在 BioRender 中完全编辑

  • 添加文本、形状及其他图标
  • 搜索 50,000 多种科学准确的图标
  • 重新着色并重新排列每一个图标、线条和标签
  • 导出或分享以满足任何使用需求
Scientist Avatars

加入 400 多万名科学家 的行列,制作可直接用于发表的图表

从图标到成品图表,只需几分钟

  • 搜索 来自 50,000 多个科学准确、经同行评审的图标
  • 自定义 添加标签、形状和更多图标——一切皆可完全编辑
  • 导出 或与协作者分享您的图表
    ‍

图标不合适?探索更多内容。

搜索涵盖 30 多个生命科学领域的 50,000 多个图标。

search icon
arrow-right
epithelium,columnar,epithelia,damage,atrophy,pseudostratified epithelium,pseudostratified epithelial cell
查看更多

尝试使用同义词,或注册以在应用中请求图标。

图像类型

Pseudostratified epithelial cell 2 (damaged) icon JPEG

Pseudostratified epithelial cell 2 (damaged) icon PNG

Pseudostratified epithelial cell 2 (damaged) icon SVG

Pseudostratified epithelial cell 2 (damaged) icon GIF

BioRender 图标常见问题解答

How are scientists using the Pseudostratified epithelial cell 2 (damaged) icon in their work?

BioRender users often use the Pseudostratified epithelial cell 2 (damaged) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Cell Types.

我可以在 BioRender 图表或科学插图中使用此图标吗?

Yes, the Pseudostratified epithelial cell 2 (damaged) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Pseudostratified epithelial cell 2 (damaged) icon customizable in BioRender?

Most icons in BioRender, including the Pseudostratified epithelial cell 2 (damaged) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Pseudostratified epithelial cell 2 (damaged) icon for publication or presentations?

Yes, figures containing the Pseudostratified epithelial cell 2 (damaged) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Pseudostratified epithelial cell 2 (damaged) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Pseudostratified epithelial cell 2 (damaged) icon — especially those focused on Cell Types. You can search BioRender’s template library or add this icon manually to any canvas.

什么是 BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Pseudostratified epithelial cell 2 (damaged) icon along with our library of more than 30,000 life science icons.

在 BioRender 中使用此图标

立即开始制作专业的科学图表
antibody elements3D Phospholipid illustration

正在寻找科学内容?

浏览超过 5 万个经同行评审、易于使用且免费的图标和模板。

立即寻找您的专属素材
x icon